About Us Services Careers FAQ Contact Us 0
Home Healthcare IT CRISPR-Cas9 Gene Editing Technologies Market Size, Demand, Report to 2032
CRISPR-Cas9 Gene Editing Technologies Market

CRISPR-Cas9 Gene Editing Technologies Market Size, Share & Trends Analysis Report By Product and Service (Reagents and Consumables, Software and Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Other technologies), By Applications (Cell Line Engineering, Genetic Engineering, Drug Discovery and Development, Other Applications), By End-User (Pharmaceutical and Biotechnology Companies , Academic and Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI215DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global CRISPR-Cas9 Gene Editing Technologies Market Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    6. U.S.
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Reagents and Consumables
          1. By Value
        3. Software and Systems
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR
          1. By Value
        3. TALEN
          1. By Value
        4. ZFN
          1. By Value
        5. ANTISENSE
          1. By Value
        6. Other technologies
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Cell Line Engineering
          1. By Value
        3. Genetic Engineering
          1. By Value
        4. Drug Discovery and Development
          1. By Value
        5. Other Applications
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies 
          1. By Value
        3. Academic and Research Institutes
          1. By Value
    7. Canada
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    6. U.K.
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Reagents and Consumables
          1. By Value
        3. Software and Systems
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR
          1. By Value
        3. TALEN
          1. By Value
        4. ZFN
          1. By Value
        5. ANTISENSE
          1. By Value
        6. Other technologies
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Cell Line Engineering
          1. By Value
        3. Genetic Engineering
          1. By Value
        4. Drug Discovery and Development
          1. By Value
        5. Other Applications
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies 
          1. By Value
        3. Academic and Research Institutes
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    6. China
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Reagents and Consumables
          1. By Value
        3. Software and Systems
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR
          1. By Value
        3. TALEN
          1. By Value
        4. ZFN
          1. By Value
        5. ANTISENSE
          1. By Value
        6. Other technologies
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Cell Line Engineering
          1. By Value
        3. Genetic Engineering
          1. By Value
        4. Drug Discovery and Development
          1. By Value
        5. Other Applications
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies 
          1. By Value
        3. Academic and Research Institutes
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    6. UAE
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Reagents and Consumables
          1. By Value
        3. Software and Systems
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR
          1. By Value
        3. TALEN
          1. By Value
        4. ZFN
          1. By Value
        5. ANTISENSE
          1. By Value
        6. Other technologies
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Cell Line Engineering
          1. By Value
        3. Genetic Engineering
          1. By Value
        4. Drug Discovery and Development
          1. By Value
        5. Other Applications
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies 
          1. By Value
        3. Academic and Research Institutes
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Reagents and Consumables
        1. By Value
      3. Software and Systems
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR
        1. By Value
      3. TALEN
        1. By Value
      4. ZFN
        1. By Value
      5. ANTISENSE
        1. By Value
      6. Other technologies
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Cell Line Engineering
        1. By Value
      3. Genetic Engineering
        1. By Value
      4. Drug Discovery and Development
        1. By Value
      5. Other Applications
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies 
        1. By Value
      3. Academic and Research Institutes
        1. By Value
    6. Brazil
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Reagents and Consumables
          1. By Value
        3. Software and Systems
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR
          1. By Value
        3. TALEN
          1. By Value
        4. ZFN
          1. By Value
        5. ANTISENSE
          1. By Value
        6. Other technologies
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Cell Line Engineering
          1. By Value
        3. Genetic Engineering
          1. By Value
        4. Drug Discovery and Development
          1. By Value
        5. Other Applications
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies 
          1. By Value
        3. Academic and Research Institutes
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. CRISPR-Cas9 Gene Editing Technologies Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Merck KGaA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific, Inc.
    3. GenScript
    4. Agilent Technologies
    5. PerkinElmer
    6. Lonza
    7. Tecan Life Sciences
    8. Sangamo Therapeutics
    9. Editas Medicine
    10. CRISPR Therapeutics AG
    11. Precision Biosciences
    12. Cellectis S.A.
    13. Intellia Therapeutics
    14. Bluebird Bio, Inc.
    15. Regeneron Pharmaceuticals
    16. AMSBIO
    17. Creative Biogene
    18. Synthego Corporation
    19. Beam Therapeutics Inc.
    20. Caribou Biosciences, Inc.
    21. OriGene Technologies
    22. New England Biolabs
    23. Inscripta
    24. Mammoth Biosciences
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.